Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/2/2020
NMPA Issues the Amended Blood Product Appendix of 2010 GMP
7/1/2020
Revisiting the Basis of Your China Strategy in the Post-Covid New Norm...
7/1/2020
Trends in U.S. Multinational Enterprise Activity in China, 2000-2017
7/1/2020
CDE Solicits Comments on the Draft CDE Guidelines for Management of Su...
7/1/2020
CDE Issues the M4 Module 1. Administrative Information and Prescribing...
7/1/2020
CDE Issues the Guidelines for Evaluation and Management of Safety Info...
7/1/2020
CDE Issues the Guidelines for Clinical Trial Registration and Informat...
7/1/2020
NMPA Reports on Crackdown of Fake and Substandard Drugs in 2019
7/1/2020
China's First COVID-19 mRNA Vaccine Approved for Clinical Trials
7/1/2020
Financial-related Company News in Brief
7/1/2020
ObsEva and Yuyuan Bio Announce Submission of Chinese Pre-IND Dossier f...
7/1/2020
NMPA Issues Announcement on Drug Registration Fee Standards and Rules
7/1/2020
NMPA Issues the Requirements for Drug Record and Data Management (Inte...
7/1/2020
CDE Issues the Guidelines for Safety Update Reporting During R&D (Inte...
6/30/2020
BeiGene Launches Amgen's XGEVA (Denosumab) in China
6/30/2020
Recent Executive Movements
6/30/2020
NMPA Issues the Chemical Drug Registration Classification and Dossier ...
6/30/2020
NMPA Issues the Biologic Product Registration Classification and Dossi...
6/30/2020
NMPA Publicizes the List of Reference Formulations for Generic Drug Eq...
6/30/2020
Fitch: No Near-Term Impact on Chinese API Makers as Pharma Supply-Chai...
6/30/2020
Ex-USPTO Head, Retired Judge Back China Pharma IP Reform
6/30/2020
Helsinn Announces Launch of Oral Formulation of Akynzeo in China
6/30/2020
How Data Protection Matters for Pharma Cos in Mainland China? - Ensuri...
6/30/2020
China to Initiate Use of a Controversial Covid-19 Vaccine in Its Milit...
6/29/2020
Lee's Pharma Gains Chinese Import Approval of Unidrox Prulifloxacin Ta...
6/29/2020
CDE Seeks Comments on the Guidelines for Use of GnRH Stimulants in Cli...
6/29/2020
Burning Rock and CStone to Co-develop Companion Diagnostics for Pralse...
6/25/2020
BeiGene's sNDA of Tislelizumab for Frontline Advanced NSCLC Accepted i...
6/25/2020
Boehringer Ingelheim's China-developed CSF Live Vaccine Approved
6/25/2020
Sinovac Receives Approval from China for its Quadrivalent Influenza Va...
Page:
270
/
813
Total number of articles:
24381
:
[First]
[<<]
[268]
[269]
[270]
[271]
[272]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit